Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 38.5(a) - UDG Healthcare plc

28th May 2021 11:13

RNS Number : 2122A
GoldmanSachs International
28 May 2021
 

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

UDG HEALTHCARE PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.05 ordinary shares

Date of dealing

27 May 2021

 

2. DEALINGS (Note 2)

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid (Note 3)

538,102

10.6100 GBP

10.5300 GBP

 

Total number of relevant securities disposed

Highest price received (Note 3)

Lowest price received (Note 3)

492,225

10.6150 GBP

10.5290 GBP

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 4)

Number of relevant securities  (Note 5)

Price per unit  (Note 3)

CFD

Reducing a short position

212

10.5289 GBP

CFD

Increasing a short position

6,887

10.5311 GBP

CFD

Increasing a short position

399

10.5311 GBP

CFD

Reducing a short position

800

10.5607 GBP

CFD

Increasing a short position

3,301

10.5645 GBP

CFD

Reducing a short position

699

10.5869 GBP

CFD

Increasing a short position

23,227

10.5936 GBP

CFD

Increasing a short position

384

10.6065 GBP

CFD

Increasing a short position

14,898

10.6121 GBP

CFD

Opening a short position

18

14.9898 USD

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 3)

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 3)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

NONE

 

Date of disclosure

28 May 2021

Contact name

Paul Grainger and Kashif Rafiq

Telephone number

+44(20) 7552 9835 / +44(20) 7051 0547

Name of offeree/offeror with which connected

UDG HEALTHCARE PLC

Nature of connection (Note 6)

Advisor to Offeree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEDKFBDKBKDBPB

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00